Speak directly to the analyst to clarify any post sales queries you may have.
Healthcare fraud detection is evolving rapidly, driven by digital transformation, advanced analytics, and increasingly complex regulatory demands. Senior decision-makers must navigate shifting threats, rising compliance expectations, and emerging technologies to safeguard revenue and patient trust.
Market Snapshot: Healthcare Fraud Detection Market Growth
The Healthcare Fraud Detection Market grew from USD 2.22 billion in 2024 to USD 2.70 billion in 2025. Projected to advance at a CAGR of 21.34%, the market is expected to achieve USD 10.47 billion by 2032. Expansion is underpinned by digitalization of claims, billing, and prescriptions, along with increased regulatory scrutiny and investment in advanced detection capabilities.
Scope & Segmentation
This report offers a comprehensive review of the healthcare fraud detection market, analyzing opportunities across components, deployment models, application areas, end users, fraud types, and geographies. The following segmentation defines the market’s breadth:
- Component: Services (Consulting, Data Integration, System Integration, Support & Maintenance) Software (Analytics — Descriptive Analytics, Predictive Analytics; Detection — Behavior Analysis, Pattern Matching; Prevention — Real-time Monitoring, Rule-based Filtering)
- Deployment: Cloud, On Premise
- Application: Billing, Claims Management, Enrollment Fraud, Prescription Fraud
- End User: Hospitals (Private, Public), Payers (Government, Private), Pharmacies (Online, Retail)
- Fraud Type: Billing Fraud, Identity Theft, Insurance Fraud, Pharmaceutical Fraud
- Region: Americas (North America, Latin America), Europe, Middle East, Africa, Asia-Pacific (Key countries and sub-regions mapped)
- Leading Companies: SAS Institute Inc., IBM Corporation, Optum, Inc., Cotiviti, Inc., Fair Isaac Corporation, Pegasystems Inc., Verisk Analytics, Inc., DXC Technology Company, NICE Ltd., LexisNexis Risk Solutions Inc.
Key Takeaways for Decision Makers
- Increasing digitalization of healthcare data is matched by the sophistication of fraud schemes, making investment in integrated, end-to-end detection frameworks essential for resilience.
- Adoption of machine learning, real-time analytics, and behavioral pattern recognition is redefining risk protocols and prompting proactive rather than reactive fraud management strategies.
- Cloud-based deployments are favored for scalability and rapid access to updates, particularly as tariff adjustments and hardware costs affect on-premise adoption.
- Collaboration across compliance, IT, and clinical teams ensures alignment with evolving privacy regulations and operational workflows, supporting more synchronized fraud defense mechanisms.
- Segmentation by use case, deployment, and region highlights that effective fraud prevention is not one-size-fits-all, requiring tailored approaches to address regional regulations and specific operational environments.
- The competitive landscape is marked by vendor specialization in analytics modules and ongoing consolidation, providing a pathway for clients to leverage bundled consulting, integration, and support services.
Tariff Impact on Healthcare Fraud Detection
Anticipated U.S. tariff adjustments in 2025 may drive up costs for imported hardware, such as monitoring and storage appliances. Organizations may respond by reevaluating vendor agreements, considering alternative sourcing, and favoring cloud-based solutions to offset capital expenditure pressures. This shift also supports faster implementation of analytics and real-time monitoring capabilities, enabling proactive responses to cost and compliance challenges.
Healthcare Fraud Detection Market: Methodology & Data Sources
Our analysis is grounded in a rigorous methodology combining comprehensive secondary research and stakeholder interviews with healthcare providers, payers, vendors, and regulatory experts. Data validation involved market modelling, consistency checks, and sensitivity analysis to ensure credible trend synthesis and actionable strategic recommendations.
Why This Report Matters
- Empowers executives to benchmark their fraud detection strategies and investments across use cases, regions, and organizational types.
- Provides actionable insights for integrating technology, compliance, and operational workflows in response to technology and policy shifts.
- Supports informed decision-making through transparent methodology and deep segmentation analysis tailored for industry leaders.
Conclusion
Healthcare fraud detection is becoming increasingly integral to operational resilience across diverse healthcare environments. Stakeholders who leverage advanced analytics, adapt to evolving regulations, and tailor solutions to local market realities will position themselves for sustained risk reduction and strategic agility.
Additional Product Information:
- Purchase of this report includes 1 year online access with quarterly updates.
- This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Table of Contents
3. Executive Summary
4. Market Overview
7. Cumulative Impact of Artificial Intelligence 2025
Companies Mentioned
The companies profiled in this Healthcare Fraud Detection market report include:- SAS Institute Inc.
- IBM Corporation
- Optum, Inc.
- Cotiviti, Inc.
- Fair Isaac Corporation
- Pegasystems Inc.
- Verisk Analytics, Inc.
- DXC Technology Company
- NICE Ltd.
- LexisNexis Risk Solutions Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 198 |
| Published | October 2025 |
| Forecast Period | 2025 - 2032 |
| Estimated Market Value ( USD | $ 2.7 Billion |
| Forecasted Market Value ( USD | $ 10.47 Billion |
| Compound Annual Growth Rate | 21.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 11 |

